TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
15 hedge funds and large institutions have $464K invested in Titan Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
1
Closed
4
Calls
$349K
Puts
$113K
Net Calls
+$236K
Net Calls Change
+$199K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$60.2K |
2 |
Geode Capital Management
Boston,
Massachusetts
|
+$59.8K |
3 |
Citadel Advisors
Miami,
Florida
|
+$55.7K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$26K |
5 |
UBS Group
Zurich,
Switzerland
|
+$19.6K |